Cargando…
Carbon Monoxide Improves Efficacy of Mesenchymal Stromal Cells During Sepsis by Production of Specialized Proresolving Lipid Mediators*
OBJECTIVES: Mesenchymal stromal cells are being investigated as a cell-based therapy for a number of disease processes, with promising results in animal models of systemic inflammation and sepsis. Studies are ongoing to determine ways to further improve the therapeutic potential of mesenchymal strom...
Autores principales: | Tsoyi, Konstantin, Hall, Sean R. R., Dalli, Jesmond, Colas, Romain A., Ghanta, Sailaja, Ith, Bonna, Coronata, Anna, Fredenburgh, Laura E., Baron, Rebecca M., Choi, Augustine M. K., Serhan, Charles N., Liu, Xiaoli, Perrella, Mark A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5113254/ https://www.ncbi.nlm.nih.gov/pubmed/27513357 http://dx.doi.org/10.1097/CCM.0000000000001999 |
Ejemplares similares
-
Human Milk Proresolving Mediators Stimulate Resolution of Acute Inflammation
por: Arnardottir, Hildur, et al.
Publicado: (2015) -
Proresolving Mediators LXB4 and RvE1 Regulate Inflammation in Stromal Cells from Patients with Shoulder Tendon Tears
por: Dakin, Stephanie G., et al.
Publicado: (2019) -
Human Periodontal Stem Cells Release Specialized Proresolving Mediators and Carry Immunomodulatory and Prohealing Properties Regulated by Lipoxins
por: Cianci, Eleonora, et al.
Publicado: (2016) -
Proresolving and cartilage-protective actions of resolvin D1 in inflammatory arthritis
por: Norling, Lucy V., et al.
Publicado: (2016) -
Proresolving and cartilage-protective actions of resolvin D1 in inflammatory arthritis
por: Norling, Lucy V., et al.
Publicado: (2023)